For job hunters CV and LinkedIn Coaching Reverse recruitment Students and academia Professionals and managers Directors and executives For employers Reviews Blog Guides Statutory roles Pharma ATS report Pharma jobs Arbeitszeugnis check Arbeitszeugnis decoder Pharma CV templates Pharma CV checker Interview ranking Job search statistics Notice period calculator Salary bands Job market pulse Hidden gem employers AI persona Newsletter About Book a free getting-to-know call
EN DE PL
← MoreThanCareer.de

Data Science & AI in Pharma Jobs 2026: RWE, Biostatistics, Machine Learning, DACH

What does data science and AI earn in DACH pharma 2026?

Data science and AI in DACH pharma pays from junior data scientist (€70,000–90,000) to head of data science (€200,000–300,000+). Key roles: real-world evidence (RWE) analyst, biostatistician (SAS, R), machine learning scientist, AI engineer (PyTorch, TensorFlow), computational biologist, MLOps engineer. AI/ML in drug discovery, oncology biostatistics, and RWE-HEOR are the best-paid specialty areas. Fully remote-capable at CROs and specialty consultancies; Big Pharma is hybrid.

What data science and AI in pharma actually does

Data science in pharma divides into multiple overlapping areas. Biostatistics: study design, power calculation, statistical analysis plan (SAP), Bayesian trial design, adaptive designs, survival analysis, mixed-effects models. SAS and R as standard. Real-world evidence (RWE): analysis of claims data (statutory health insurance), electronic health records, registries; applied to HEOR, post-marketing studies, outcomes research. AI/ML in drug discovery: protein structure prediction (AlphaFold), generative chemistry, virtual screening, ADMET prediction, quantitative systems pharmacology. Clinical data science: SDTM/ADaM datasets, risk-based quality management, centralised statistical monitoring. Computational biology: genomics, single-cell, multi-omics, pathway analysis. MLOps: model lifecycle, validation per GxP, containerisation (Docker, Kubernetes), cloud (AWS, Azure, GCP).

Who hires data science pharma in DACH

Big Pharma data science hubs: Bayer (Berlin, Leverkusen), Roche (Basel, Penzberg), Novartis (Basel, Zurich AI Innovation Center), Pfizer (Berlin), Boehringer Ingelheim (Biberach), Merck KGaA (Darmstadt), Sanofi (Frankfurt, Cambridge/USA), AstraZeneca (Cambridge/UK plus DACH sites), GSK (London, Stevenage plus DACH), AbbVie, Lilly. Specialty biotech with AI focus: BioNTech (Mainz, AI Innovation Lab), Curevac (Tübingen), Recursion Pharmaceuticals (US/EU), Insitro, Exscientia (Oxford plus DACH partnerships), Atomwise. CROs with RWE and biostatistics: ICON Biostatistics, IQVIA RWE (Real-World Evidence Center of Excellence Frankfurt), Parexel Biostatistics, Syneos Health Biostatistics, Labcorp Biostatistics, Cytel, Veramed, PHASTAR. AI-first pharma consultancies: BCG Vantage, McKinsey QuantumBlack, Bain Vector, Accenture Life Sciences AI. High-density locations: Berlin (Bayer, Pfizer), Basel (Roche, Novartis), Zurich (Novartis AI), Mainz (BioNTech), Heidelberg (BioMed X, EMBL).

Data science pharma salary bands DACH 2026

Junior data scientist (pharma) €70,000–90,000, data scientist II €90,000–115,000, senior data scientist €115,000–145,000. Principal data scientist / lead €145,000–180,000. Biostatistician €80,000–110,000, senior biostatistician €110,000–140,000, principal biostatistician €140,000–175,000. RWE specialist €85,000–115,000, senior RWE €115,000–145,000. ML scientist / AI engineer €100,000–145,000, senior ML scientist €145,000–185,000. Computational biologist €90,000–130,000, senior computational biologist €130,000–165,000. Head of biostatistics €175,000–230,000. Head of AI / head of data science €200,000–300,000+ plus stock awards at US pharma and tech pharma. Bonus 15–25%, stock/RSU at US companies standard. AI/ML in drug discovery pays a 10–20% premium over traditional biostatistics.

The hidden data science job market

Most junior to senior data scientist roles are advertised (LinkedIn, Sciencecareers, AI job boards, pharma career portals); across the German market, personal contacts decided 27 per cent of hires in 2025 (IAB-Stellenerhebung). For principal data scientist and lead roles, my estimate from 17 years of recruiting is that 60 to 70 per cent are filled without a public advert, often through specialist headhunters (Quanta Consultancy AI, Real Staffing Data Science, Hays Life Sciences Data, ProClinical Data, Trinity AI Talent, Klein Hersh). Head of biostatistics and head of AI roles sit at the upper end of that range. Egon Zehnder, Russell Reynolds, Heidrick & Struggles, Spencer Stuart for senior executive search. Hot areas with the highest hidden share: generative AI in drug discovery, MLOps with GxP compliance, causal inference in RWE, multi-omics integration.

Data science pharma career paths in DACH

Standard paths: PhD-to-industry, PhD in statistics, computer science, computational biology, bioinformatics, physics, mathematics (3–5 years) → postdoc or direct industry entry → senior data scientist after 3–5 years. Cross-industry: from tech (Google, Meta, Microsoft) or consulting (McKinsey, BCG) into pharma AI, with 10–25% pay cut at Big Pharma, often compensated by specialty biotech with stock awards. Biostatistics track: MSc biostatistics → junior biostatistician → senior after 5–7 years. AI/ML track: PhD computer science / machine learning → industry postdoc or direct entry → senior ML scientist after 3–5 years. Specialty domains (oncology biostatistics, AI drug discovery, MLOps pharma) accelerate careers. My Reverse Recruitment covers roles in Germany: it helps plan tech-to-pharma moves or academia-to-pharma moves precisely and builds the application for every role you green-light, which I submit in your name once you approve it. Whichever country the role is in, my service is application support only, not job placement and not a recruitment agency service (in German law: Arbeitsvermittlung and Personalvermittlung); you are the applicant and I contact no employer on your behalf. For roles outside Germany, Switzerland included, I work as your coach and you send every application yourself.

Frequently asked questions

Do I need a PhD for data science in pharma?

Biostatistics often an MSc in biostatistics or related; AI/ML, computational biology, and principal-level data science have PhD as standard at 70–80% of senior roles. RWE roles are more open to MSc with significant industry experience. US pharma and specialty biotech prioritise PhD more strongly; generics and service CROs less.

Which data science specialisation pays best in DACH 2026?

Generative AI in drug discovery (LLMs, diffusion models in chemistry), MLOps with GxP compliance, causal inference in RWE, and oncology biostatistics (Bayesian designs, synthetic control arms) pay a 15–25% premium. Senior ML scientist with generative AI expertise €160,000–200,000 in Big Pharma, €180,000–250,000 in specialty biotech with RSUs.

Is data science in pharma 2026 remote-capable?

Fully remote at CROs (ICON Biostatistics, IQVIA RWE, Cytel, PHASTAR), specialty biotech sites with hub model, and AI-first pharma consultancies (Vantage, QuantumBlack, Vector). Big Pharma 2024–2026 increasingly hybrid (2–3 days office) for senior roles; remote contracts still possible for specialty expertise and pre-COVID employees.

Want a clearer route to one of these roles?

Twenty minutes to get to know each other, no agenda, no pressure. For data science roles the usual entry points are the Pharma Professional CV package (€299, or €399 with LinkedIn), interview coaching at €349 and, for roles in Germany, reverse recruitment from €3,950.

Book a free getting-to-know call